EVAS How does this Impact EVAR Therapy
|
|
|
- Jeffrey Stevens
- 5 years ago
- Views:
Transcription
1 EVAS How does this Impact EVAR Therapy John S. Lane III, MD, FACS Professor and Acting Chief of Vascular Surgery University of California, San Diego PNEC, 2017 Endologix products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the Instructions for Use for complete and specific indications, contraindications, all warnings and precautions. Rx only.
2 DISCLOSURES John Lane, MD Consultant/Advisory Board: Endologix Speakers Bureau: Endologix Endologix products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the Instructions for Use for complete and specific indications, contraindications, all warnings and precautions. Rx only.
3 EVAR has an early survival benefit but an inferior late survival compared with open repair, which needs to be addressed by lifelong surveillance of EVAR and prompt reintervention if necessary.
4 EndoVascular Aneurysm Sealing (EVAS) IS NOT EVAR New therapy, potentially disruptive Conceptually different to EVAR Fundamental evolution in concept to using polymer to treat entire aneurysm Active management of aneurysm sac, reduce type II endoleaks Fundamentally different procedure requires adherence to SPS (Selection, Placement, Sealing)
5 Nellix IDE 1 Year Outcomes 2 Year Outcomes Primary safety and effectiveness endpoints have been achieved 100% technical success obtained Lowest overall endoleak (3.1%) and secondary intervention (3.3%) rates reported at 1-year as compared to FDAapproved EVAR devices Successful at treating a broad range of infrarenal AAA and common iliac artery aneurysms Preliminary results showed unexpected outcomes in a limited number of patients Reports of migration and aneurysm enlargement were observed Comprehensive engineering evaluation, statistical analysis, and clinical assessment were completed
6 NELLIX STENT MIGRATION Thrombus plays primary role Small blood volumes Asymmetric or inadequate endobag filling Mechanism is lateral displacement and bending Resistance to Migration Seal zone engagement Thrombus volume and stability Polymer thickness and distribution
7 NELLIX AND SAC EXPANSION Iliac artery morphology implicated OR for sac expansion 23/cm iliac diameter Lack of bag attachment 3SQ Incomplete treatment iliac aneurysm Sac expansion 2o migration
8 Indication Refinements
9 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) IFU REFINEMENT AND MIGRATION (10mm) 100.0% 99.4% 97.5% 92.5% Freedom From Migration > LEGEND OFF IFU Month SURVIVAL ESTIMATES: At Risk OFF IFU
10 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) IFU REFINEMENT AND SAC GROWTH 99.2% 99.5% 98.1% 93.8% Freedom From Sac Enlargement LEGEND OFF IFU Month SURVIVAL ESTIMATES: At Risk OFF IFU
11 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) IFU REFINEMENT AND TYPE1A ENDOLEAK 100.0% 97.4% 98.9% 96.5% Freedom From Type IA Endoleaks LEGEND OFF IFU Month SURVIVAL ESTIMATES: At Risk OFF IFU
12 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) TREATMENT FAILURE IN COHORT 99.2% 97.4% 95.6% 84.7% Freedom From Type IA Endoleaks, Sac Enlargement, or Migration > LEGEND OFF IFU 96% Freedom from Migration, Type Ia Endoleak, or Sac Expansion Freedom from Core Lab-Reported Migration >5mm Type Ia Endoleak Sac Enlargement >5mm Month SURVIVAL ESTIMATES: At Risk ON OFF
13 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) MORTALITY - ARM / ACM 98.5% 99.5% 98.5% 98.7% 92.9% 97.9% 92.0% 94.7% Freedom From AAA-Related Mortality LEGEND OFF IFU Freedom From Overall Mortality* LEGEND OFF IFU Month Month SURVIVAL ESTIMATES: At Risk SURVIVAL ESTIMATES: At Risk OFF IFU OFF IFU * 10 deaths total in each group.
14 ACTIVE MANAGEMENT ANEURYSM SAC ENDOLEAK RATE 99.2% Persistence Incidence 97.0% Type II Endoleak Global Registry < 1% of Persistent Type II Endoleaks at 2 years
15 EVAS AND PERSONALIZED MEDICINE EVAS is particularly suited for AAA with low thrombus burden EVAS reduces Type 2 Endoleak EVAS low rate sac expansion SAC EXPANSION TYPE 2 ENDOLEAKS EVAR EVAS CLINICAL RESULTS +/- +++
16 ACTIVE ANEURYSM SAC MANAGEMENT PIS and CVM 99% Freedom from Cardiovascular Mortality through 2 Years 98.5% 97.4% 89.1% CVM ARM ACM 99% Freedom from Cardiovascular Mortality through 2 Years
17 Why would EVAS carry a lower ACM and CVM than EVAR? EVAR is associated with acute sac thrombosis EVAS minimal acute thrombosis Acute thrombosis may trigger a systemic inflammatory response (Post-Implantation Syndrome) and influence post-operative outcomes
18 IFU Refinement And Clinical Outcomes (Expansion, Migration, Type 1 Endoleak) AAA METABOLISM AND ALL CAUSE MORTALITY AAA sac remains biologically active after EVAR Cytokine levels after EVAR are highest in aneurysms that remain static or expand MACE associated with systemic inflammation Lowering markers of systemic inflammation prevent MACE Role of EVAS in long term cardiovascular mortality? Otterhag et al Cytokine 2014; 70: 151 Ridker et al NEJM 2008; 20: 359
19 Why would EVAS carry a lower ACM and CVM than EVAR? Potential reduction in post-implantation syndrome and inflammatory response following endovascular aneurysm sealing EVAS (n=69) or EVAR (n=42); Lower MAEs in EVAS (10%) vs. EVAR (40%); Lower rate of cardiac AE after EVAS (2.4%) vs. EVAR (11.6%) EVAR) No endoleaks in the EVAS group; 8 (11.6%, p<0.5) in EVAR group Metabolic activity: Metabolic activity: Berg et al., Pending Publication CRP mg/dl WBC Leucocytes x 10^3/µl Platelets Thrombocytes x 10^3/µl Temp C N EVAS EVAR p<0.05 p<0.05 NS p<0.05
20 Conclusions - EVAS Low endoleak, rupture, and mortality rates through 2 years Migration signal at 2 years in AAA with large thrombus burden IFU Refinements demonstrated high freedom from Type Ia endoleak, migration, and sac growth Nellix well suited with patients with low AAA thrombus burden, and with patient lumbars, IMA Relationship between EVAS, reduction in post implant syndrome and CV mortality warrants further investigation
EVAS using Nellix in my practice Where are we today?
EVAS using Nellix in my practice Where are we today? Prof. dr. Michel MPJ Reijnen Department of Vascular Surgery, Rijnstate Hospital Arnhem Faculty of Science and Technology, University of Twente The Netherlands
Influence of patient selection and IFU compliance on outcomes following EVAS
Influence of patient selection and IFU compliance on outcomes following EVAS LUNCH SYMPOSIUM LINC 2017 Jan MM Heyligers, MD, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg,
EVAS is Associated with Lower All-Cause Mortality
EVAS is Associated with Lower All-Cause Mortality Marc L Schermerhorn, MD Chief, Division of Vascular and Endovascular Surgery Beth Israel Deaconess Medical Center Professor of Surgery Harvard Medical
Important Update to Field Safety Notice Nellix EndoVascular Aneurysm Sealing System Updated Instructions for Use (IFU)
October 6, 2017 Important Update to Field Safety Notice Nellix EndoVascular Aneurysm Sealing System Updated Instructions for Use (IFU) Dear Physician, This notification is to provide you with further information
Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?
February 1, 2018 Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages? Patrick Berg M.D. Marienhospital Kevelaer Germany
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
Is EVAS a proper choice in women?
Is EVAS a proper choice in women? CACVS 2018 Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg The Netherlands Disclosures Consultant for Endologix DEVASS =Dutch
EndoVascular Aneurysm Sealing (EVAS) with Nellix
1 2 EndoVascular Aneurysm Sealing (EVAS) with Nellix Designed to seal entire aneurysm with contained biostable polymer Non-modular design with complete fixation Expands endovascular patient eligibility
Mid-term results of 300+ patients treated by endovascular aortic sealing (EVAS)
Mid-term results of 300+ patients treated by endovascular aortic sealing (EVAS) Jean-Paul P.M. de Vries Dept Vascular Surgery St. Antonius Hospital, Nieuwegein,The Netherlands On behalf of the DEVASS study
The Auckland Experience with the Nellix EVAS System. Andrew Holden, MBChB, FRANZCR
The Auckland Experience with the Nellix EVAS System Andrew Holden, MBChB, FRANZCR Disclosure Speaker name: Associate Professor Andrew Holden I have the following potential conflicts of interest to report:
Abdominal Aortic Aneurysm (AAA)
Abdominal Aortic Aneurysm (AAA) Vascular Workshop: Objectives Anatomy Keith VanHaltren Indications Technique Cases Abdominal Aorta: Normal Size Abdominal aortic aneurysm: Definition Normal diameter of
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital Disclosures Andrew Holden, MBChB, FRANZCR No financial investment to disclose Investigator
CAUTION: The Nellix EndoVascular Aneurysm Sealing System is an investigational device. Limited by federal (or United States) law to investigational
Safety and Effectiveness Results of the Nellix System IDE Pivotal Trial for Endovascular Aneurysm Sealing PRESENTED BY: Jeffrey P. Carpenter, MD National Principal Investigator Professor and Chairman,
Improving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
Nellix Endovascular System: Clinical Outcomes and Device Overview
Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation
Treatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands
Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting
EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes?
D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes? Disclosures Speaker name: Dittmar Böckler
Current Status of EVAR for Infrarenal AAA. 31 st Annual Florida Vascular Society. PENN Surgery
Current Status of EVAR for Infrarenal AAA 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Stent Grafts Design Related Differences What really matters? Modular Unibody Supported Unsupported
Faculty Disclosure. Glue, Particulates, Thrombin, Coils and the Kitchen Sink for Type II Endoleak Management. Background.
Glue, Particulates, Thrombin, Coils and the Kitchen Sink for Type II Endoleak Management Faculty Disclosure I disclose the following financial relationships: UCSF Vascular Symposium 2013 Receive grant/research
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg Disclosure
Talent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies Jean-Paul P.M. de Vries Head Department of Surgery, University Medical Centre Groningen The
NASDAQ: ELGX December Innovation that Empowers
NASDAQ: ELGX www.endologix.com December 2014 Innovation that Empowers Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
Optimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium Disclosure Speaker name: Isabelle Van Herzeele I have the following potential
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs Jean-Paul P.M. de Vries, Richte C.L. Schuurmann St. Antonius Hospital Nieuwegein, The Netherlands 21st Critical Issues Congress Nuernberg,
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
The Ventana Off-the-Shelf Graft for Pararenal AAA. Andrew Holden Associate Professor of Radiology Auckland Hospital
The Ventana Off-the-Shelf Graft for Pararenal AAA Andrew Holden Associate Professor of Radiology Auckland Hospital Disclosures Andrew Holden, MBChB, FRANZCR Investigator in Nellix and Ventana Trials Clinical
Chimney endovascular aneurysm sealing (ch-evas) for ruptured abdominal aortic aneurysms (AAA) due to type Ia endoleak following failed EVAS
Chimney endovascular aneurysm sealing (ch-evas) for ruptured abdominal aortic aneurysms (AAA) due to type Ia endoleak following failed EVAS Saritphat Orrapin MD FRCS (Thailand), Thoetphum Benyakorn, Tunyarat
My personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
14F OD Ovation Abdominal Stent Graft System
14F OD Ovation Abdominal Stent Graft System 2 Year Results from the European Study Dierk Scheinert, MD Center for Vascular Medicine Angiology and Vascular Surgery Park Hospital Leipzig, Germany Disclosure
Abdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
Treating very short necks ( 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights
Treating very short necks ( 4mm
Challenging anatomies demand versatility.
Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA167; Endovascular stent-grafts for abdominal aortic aneurysms Final recommendation post consultation The guidance should
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes. Prof Peter Holt St George s, London
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes Prof Peter Holt St George s, London Disclosure Speaker name: Prof Peter Holt I have the following potential conflicts
Ovation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic
Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
Anatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC
Anatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton, FL, USA Disclosures
TriVascular Ovation Prime Abdominal Stent Graft System
TriVascular Ovation Prime Abdominal Stent Graft System Science of the Seal O-Ring Sealing Technology O-Ring Sealing in Proven Engineering Solutions O-rings are designed to seal by blocking the flow of
From 1996 to 1999, a total of 1,193 patients with
THE ANEURX CLINICAL TRIAL AT 8 YEARS Lessons learned following the US AneuRx clinical trial from 1996 to 2004. BY CHRISTOPHER K. ZARINS, MD From 1996 to 1999, a total of 1,193 patients with infrarenal
Durability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
Durable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
Analysis of Type IIIb Endoleaks Encountered with Endologix Endografts
Analysis of Type IIIb Endoleaks Encountered with Endologix Endografts Alan R. Wladis, MD, FACS, David Varnagy, MD, FACS, Manuel R. Perez-Izquierdo, MD, Mark Ranson, MD FACS, Delos Clift, MD FACS, Rebecca
symptomatic aneurysms or aneurysms that grow >1cm/yr
1. Elective repair for aneurysm >5.5 cm, symptomatic aneurysms or aneurysms that grow >1cm/yr 2. Ruptured AAA Aneurysm Detection and Management Study (ADAM) and UK Small Aneurysm Trial early open surgery
Access More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs JEAN-PAUL P.M. DE VRIES, DIRECTOR OF VASCULAR SURGERY ST.ANTONIUS HOSPITAL NIEUWEGEIN, THE NETHERLANDS. LINC ASIA-PACIFIC HongKong,
INCRAFT system: Update from the Pivotal INSPIRATION Study
INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh
Use of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies:
Use of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies: technical tips, case experience and clinical results CACVS Medtronic Symposium Paris, France January
Lessons learned from Ch-EVAR for the treatment of. Miltos Matsagkas MD, PhD, FEBVS Professor of Vascular Surgery University of Thessaly
Lessons learned from Ch-EVAR for the treatment of pararenal AAAs Miltos Matsagkas MD, PhD, FEBVS Professor of Vascular Surgery University of Thessaly Ch-EVAR Ch-EVAR = Chimney-EVAR Placement of single
Why Nellix? Treating Concomitant Common Iliac Aneurysms
INDICATIONS FOR USE The Nellix EndoVascular Aneurysm Sealing System can be used in patients who have an infrarenal abdominal aortic (AAA) or aortoiliac aneurysm with suitable anatomy as indicated below:
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
Endovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
2015 Clinical Update Endovascular Systems for AAA Repair
Endovascular Systems for AAA Repair 2 Musick Irvine, CA 92618 Tel 949.595.7200 Fax 949.612.1893 www.endologix.com TABLE OF CONTENTS Section Page ABSTRACT... 3 READER S GUIDE... 4 SECTION 1: US PIVOTAL
Prof. Franco Grego. Predictors of endoleak type II risk, in the era of prevention with aneurysm sac filling
UNIVERSITY OF PADUA DEPARTMENT OF VASCULAR AND ENDOVASCULAR SURGERY Director: Prof. F. GREGO Predictors of endoleak type II risk, in the era of prevention with aneurysm sac filling during EVAR Prof. Franco
Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Young-Guk Ko, M.D., Dangas G, J Am Coll Cardiol Intv 2012;5:1071 All-cause Mortality Dangas Severance G, J Am Coll Cardiovascular Cardiol Intv Hospital, 2012;5:1071 Yonsei University Health System Aneurysm-related
History of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
THE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY
THE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY Patrice Mwipatayi FCS (SA), MMed, FRACS Professor of Vascular surgery Royal Perth Hospital, University of Western Australia, Perth, WA Co-Authors:
Now that Endoanchors are Approved (and paid for) We have a Durable Solution to Short Necks That s so Easy!
Now that Endoanchors are Approved (and paid for) We have a Durable Solution to Short Necks That s so Easy! David H. Deaton, MD Vascular Surgery / University of South Carolina / Palmetto Health Chief Medical
Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
Hostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
Conflicts of Interest. When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Summary. Infrarenal EVAR for short necks 2y postop
When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Tim Resch MD Vascular Center Skane University Hospital Conflicts of Interest COOK Medical - Consulting, Speakers Bureau, IP, Research support Medtronic
Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)
Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands
Abdominal Aortic Aneurysms. A Surgeons Perspective Dr. Derek D. Muehrcke
Abdominal Aortic Aneurysms A Surgeons Perspective Dr. Derek D. Muehrcke Aneurysm Definition The abnormal enlargement or bulging of an artery caused by an injury or weakness in the blood vessel wall A localized
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
Taming The Aorta. David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA
Taming The Aorta David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA Faculty Disclosure Consulting: Endologix, Cook 1 Objectives Review the
Robert F. Cuff, MD FACS SHMG Vascular Surgery
Robert F. Cuff, MD FACS SHMG Vascular Surgery Objectives To become familiar with the commercially available fenestrated EVAR graft Discuss techniques to increase success Review available data to determine
Ultrasound Evaluation after EVAR: (Trying to) Let the CAT Scan Out of the Bag
Ultrasound Evaluation after EVAR: (Trying to) Let the CAT Scan Out of the Bag Joseph-Vincent V. Blas, MD Division of Vascular Surgery Department of Surgery Greenville Health System University of South
The clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study,
The clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study, the 36 mm diameter Zenith Flex AAA Endovascular Graft
Anatomical challenges in EVAR
Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting
Innovation forum EVAR
Innovation forum EVAR Preliminary results of expanding indications for treatment with standard EVAR in patients with challenging anatomies, a multi-centric prospective evaluation (EXTREME) study Pasqualino
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
A New EVAR Device for Infrarenal AAAs
A New EVAR Device for Infrarenal AAAs Peter Nelson, MD, MS Assistant Professor of Surgery MM0203 Rev. 01 Current U.S. EVAR Devices Anatomical Fixation Proximal Fixation Powerlink - Endologix Excluder WL
Approaches to type II Endoleaks: Transcaval, transarterial, translumbar. Saher Sabri,MD University of Virginia
Approaches to type II Endoleaks: Transcaval, transarterial, translumbar Saher Sabri,MD University of Virginia Saher Sabri, M.D. Speakers Bureau: W.L.Gore & Associates, Abbott Type 2 Endoleaks after EVAR
Endovascular options of treating iliac aneurysms
Endovascular options of treating iliac aneurysms Marek Majewski Department of Vascular Surgery of P. Desgranges Henri Mondor Hospital University Paris XII Créteil, France Common Iliac Artery Aneurysms
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 2018 Abstract. Section I GORE TAG Device Clinical experience. Section II Conformable
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 08 Abstract This annual clinical update provides a review of the ongoing experience with the GORE TAG Thoracic Endoprosthesis There have
Description. Section: Surgery Effective Date: April 15, Subsection: Surgery Original Policy Date: December 6, 2012 Subject:
Last Review Status/Date: March 2015 Page: 1 of 6 Description Wireless sensors implanted in an aortic aneurysm sac after endovascular repair are being investigated to measure post procedural pressure. It
When and where EVAR patients should be discharged?
When and where EVAR patients should be discharged? Joost A. van Herwaarden University Medical Center Utrecht The Netherlands Disclosure of Interest I have the following potential conflicts of interest
Case Report Early and Late Endograft Limb Proximal Migration with Resulting Type 1b Endoleak following an EVAR for Ruptured AAA
Hindawi Case Reports in Vascular Medicine Volume 2017, Article ID 4931282, 5 pages https://doi.org/10.1155/2017/4931282 Case Report Early and Late Endograft Limb Proximal Migration with Resulting Type
Endovascular Aneurysm Sealing System for Treating Abdominal Aortic Aneurysms: Early Outcomes from a Single Center
Endovascular Aneurysm Sealing System for Treating Abdominal Aortic Aneurysms: Early Outcomes from a Single Center Thiti Chanmayka MD*, Anucha Ahooja MD**, Chalach Mitprachapranee MD*, Chawalit Wongbhuddha
Zenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up
Zenith Renu AAA Converter Graft Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Device description: Device indications The Zenith Renu AAA Converter Graft with Z-Trak Introduction
EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck. Inflammatory response after EVAR: causes and clinical implication
39 th Annual Meeting, Boston, Sept. 2012 EVAR follow up: answers to uncertainties Moderators F. Moll, Y. Alimi, M. Bjorck Inflammatory response after EVAR: causes and clinical implication Christos D. Liapis,
Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm
LINC 2019 Leipzig, Germany Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm Deokbi Hwang, Sujin Park, Hyung-Kee Kim, Seung Huh Division
ChEVAR Vs. fevar for juxtarenal Aneurysm. E.Ducasse MD PhD FEVBS Unit of vascular surgery CHU bordeaux
ChEVAR Vs. fevar for juxtarenal Aneurysm E.Ducasse MD PhD FEVBS Unit of vascular surgery CHU bordeaux CH-EVAR VS. F-EVAR IN JAAAs Meta-analysis, 2001-2012 5 CH-EVAR studies (94 patients, 151 target vessels)
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results Konstantinos P. Donas, Giovanni Torsello Department of Vascular Surgery St. Franziskus Hospital Münster, Germany Disclosure Speaker
Degeneration of the Neck Post Implementation - a New Era of AAA Stent
Degeneration of the Neck Post Implementation - a New Era of AAA Stent New Mexico Heart Institute Albuquerque, New Mexico USA - Gore Current FDA-Approved EVAR Devices Sealing Mechanism Endologix Lombard
EVAS Sealing Technology: The new paradigm in AAA therapy
June 2016 EDUCATIONAL SUPPLEMENT EVAS Sealing Technology: The new paradigm in AAA therapy This educational supplement has been supported by an unrestricted educational grant from Endologix MM1398 Rev 01
Hostile Proximal Neck: A New Conformable EVAR Device
Hostile Proximal Neck: A New Conformable EVAR Device Young-Guk Ko, M.D., Seoul, Korea Currently Available Devices for EVAR in Korea, 2018 Zenith Flex, Cook Endurant IIs, Medtronic INCRAFT, Cordis AFX2,
Reinterventions After Fenestrated and Branched Endovascular Aortic Aneurysm Repair
Reinterventions After Fenestrated and Branched Endovascular Aortic Aneurysm Repair Andres Schanzer, MD Division of Vascular and Endovascular Surgery UMass Medical School June 15 th, 2018 PNEC, Seattle,
SaC embolization Per EVAR: results from a prospective randomized study SCOPE 1
SaC embolization Per EVAR: results from a prospective randomized study SCOPE 1 Dominique Fabre, Frederic Cochennec, Claude Angel, Eric Allaire, Philippe Brenot, Riyad Bourkaib,Jean-yves Riou, Pascal Desgranges,
Considerations for a Durable Repair
Considerations for a Durable Repair Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany Disclosures William Cook
Trattamento Endovascolare degli Aneurismi dell Aorta Addominale con Colletto Prossimale Ostile:
Trattamento Endovascolare degli Aneurismi dell Aorta Addominale con Colletto Prossimale Ostile: Risultati Precoci e a Medio Termine in Esperienza Monocentrica A.Lauricella - R.Silingardi Chirurgia Vascolare,
Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization
Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization Thomas Larzon, MD, PhD Head of Vascular Surgery Dept of Cardiothoracic
FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX
FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX 2018 A BIT OF HISTORY First use of F-EVAR : 1990s Park et al. J Vasc Interv Radiol. 1996;7:819-823. Faruqi et al. J Endovasc Surg.
Aorfix Pythagoras US Clinical Trial:
Overall 1 Year Results from the Aorfix Pythagoras US Clinical Trial: 1 st IDE Study in Highly Angulated 60 133 Aortic Necks Mark Fillinger MD for the PYTHAGORAS Investigators Disclosure Speaker name: Mark
The Fate of Unexpected Events Occurring in Standard EVAR
The Fate of Unexpected Events Occurring in Standard EVAR Andrea Stella Alma Mater Studiorum - University of Bologna Disclosure Speaker name: Prof. Andrea Stella I have the following potential conflicts
An Overview of Post-EVAR Endoleaks: Imaging Findings and Management. Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC
An Overview of Post-EVAR Endoleaks: Imaging Findings and Management Ravi Shergill BSc Sean A. Kennedy MD Mark O. Baerlocher MD FRCPC Disclosure Slide Mark O. Baerlocher: Current: Consultant for Boston
MODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE
MODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE AAA FACTS 200,000 New Cases Each Year Ruptured AAA = 15,000 Deaths per Year in U.S. 13th Leading Cause of Death 80% Chance of
Disclosures. EVAR follow-up: actual recommendation. EVAR follow-up: critical issues
Disclosures is it time to discuss individualized follow-up schemes based on preoperative anatomy and high quality completion angiography? Consultant / Speaker / Proctor Cook Cordis Medtronic Invatec W.L.